ONCY

#3426
Oncolytics Biotech Inc. - Common Stock
1.0 4 USD
+10.64%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
1.04
1.04
년간 변동
0.33
1.51
일일 변동
+10.64%
월간 변동
+14.29%
6달 변화
+4.00%
년간 변동율
+173.68%
이전 종가
0.9 4
Open
1.0 4
저가
1.0 4
High
1.0 4
양
30
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 124.13 M
  • Employee 29
  • Founded 1998
  • CEO N/A
  • Website www.oncolyticsbiotech.com
  • Headquarter Nevada, United States
  • FIGI BBG000DVS826
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-2.91
주가매출액비율
-169.59

Oncolytics Biotech Inc. - Common Stock

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

뉴스